Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Akoya to Participate at Two Upcoming Investor Conferences By: Akoya Biosciences, Inc. via GlobeNewswire June 12, 2023 at 16:05 PM EDT MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in two upcoming investor conferences. Capital One Securities 2nd Annual Spatial Biology and Proteomics Virtual Research Summit“Pushing the Envelope of Technology with Increased Sensitivity and Higher Plex on the Horizon” Panel on Tuesday, June 20th at 10:30 AM ETNiro Ramachandran, CBO TD Cowen 2nd Annual Tools/Dx Revolution“Spatial – The Next Frontier: Clinical” Panel on Monday, June 26th at 4:20 PM PTBrian McKelligon, CEO A live and archived webcast of the Capital One event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com. Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com Media Contact:Christine Quern(617) 650-8497media@akoyabio.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Akoya to Participate at Two Upcoming Investor Conferences By: Akoya Biosciences, Inc. via GlobeNewswire June 12, 2023 at 16:05 PM EDT MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in two upcoming investor conferences. Capital One Securities 2nd Annual Spatial Biology and Proteomics Virtual Research Summit“Pushing the Envelope of Technology with Increased Sensitivity and Higher Plex on the Horizon” Panel on Tuesday, June 20th at 10:30 AM ETNiro Ramachandran, CBO TD Cowen 2nd Annual Tools/Dx Revolution“Spatial – The Next Frontier: Clinical” Panel on Monday, June 26th at 4:20 PM PTBrian McKelligon, CEO A live and archived webcast of the Capital One event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com. Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com Media Contact:Christine Quern(617) 650-8497media@akoyabio.com
MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in two upcoming investor conferences. Capital One Securities 2nd Annual Spatial Biology and Proteomics Virtual Research Summit“Pushing the Envelope of Technology with Increased Sensitivity and Higher Plex on the Horizon” Panel on Tuesday, June 20th at 10:30 AM ETNiro Ramachandran, CBO TD Cowen 2nd Annual Tools/Dx Revolution“Spatial – The Next Frontier: Clinical” Panel on Monday, June 26th at 4:20 PM PTBrian McKelligon, CEO A live and archived webcast of the Capital One event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com. Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com Media Contact:Christine Quern(617) 650-8497media@akoyabio.com